The Current Ratio as of December 2024 (TTM) for ZIVO Bioscience, Inc. (ZIVO) is 0.17

According to ZIVO Bioscience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.17. This represents a change of -6.74% compared to the average of 0.18 of the last 4 quarters.

ZIVO Bioscience, Inc. (ZIVO) Historical Current Ratio (quarterly & annually)

How has ZIVO Current Ratio performed in the past?

The mean historical Current Ratio of ZIVO Bioscience, Inc. over the last ten years is 0.43. The current 0.17 Current Ratio has changed 3.80% with respect to the historical average. Over the past ten years (40 quarters), ZIVO's Current Ratio was at its highest in in the September 2021 quarter at 3.08. The Current Ratio was at its lowest in in the March 2019 quarter at 0.00.

ZIVO Bioscience, Inc. (ZIVO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ZIVO Bioscience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ZIVO Bioscience, Inc. (ZIVO) Average Current Ratio

How has ZIVO Current Ratio performed in the past?

The current Current Ratio of ZIVO Bioscience, Inc. (ZIVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ZIVO Bioscience, Inc. (ZIVO) Current Ratio vs. Peers

How is ZIVO’s Current Ratio compared to its peers?

ZIVO Bioscience, Inc.’s Current Ratio is less than RenovoRx, Inc. (5.66), less than Pasithea Therapeutics Corp. (14.81), less than Quoin Pharmaceuticals, Ltd. (3.02), less than ARCA biopharma, Inc. (26.61), less than Theseus Pharmaceuticals, Inc. (0), less than Erasca, Inc. (29.93), less than Forte Biosciences, Inc. (11.00), less than Applied Molecular Transport Inc. (2.06), less than Senti Biosciences, Inc. (4.99), less than Cadrenal Therapeutics, Inc. Common Stock (1.92), less than Foghorn Therapeutics Inc. (3.69), less than Tempest Therapeutics, Inc. (4.77), less than Ikena Oncology, Inc. (1.69), less than Catalyst Biosciences, Inc. (15.32), less than null (3.72),

Build a custom stock screener for ZIVO Bioscience, Inc. (ZIVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZIVO Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ZIVO Bioscience, Inc. (ZIVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ZIVO Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.